Date 24 Oct 2025
Title Q3 2025 Trading Update - IMC
Link
Date 24 Oct 2025
Title Q3 2025 Trading Update Presentation
Document
Date 01 Oct 2025
Title ACCRUFeR® Phase 3 pediatric trial presentation at the American Association of Pediatrics (AAP) Conference
Document
Date 22 May 2025
Title Results of 2025 AGM
Document
Date 30 Apr 2025
Title FY 2024 and Q1 2025 Trading Update
Link
Date 25 Apr 2025
Title Annual Report and Accounts for the year ended 2024
Document
Date 25 Apr 2025
Title Notice of 2025 AGM
Document
Date 25 Apr 2025
Title Letter to shareholders
Document
Date 24 Apr 2025
Title 2024 Full Year Results & Q1 2025 Presentation
Document
Date 28 Feb 2025
Title Shield Therapeutics plc - Corporate Presentation
Document
Date 24 Feb 2025
Title Anders Lundstrom CEO - 2024 Year in Review & Strategic Outlook for 2025
Document
Date 06 Feb 2025
Title Q4 and FY 2024 Unaudited Trading Update
Link
Date 06 Dec 2024
Title Shareholder Circular
Document
Date 06 Dec 2024
Title Peel Hunt Consent Letter
Document
Date 06 Dec 2024
Title AOP Irrevocable Undertaking
Document
Date 06 Dec 2024
Title Director's Irrevocable Undertaking - Hans Peter Hasler
Document
Date 06 Dec 2024
Title Directors's Irrevocable Undertakings - P Llewellyn-Davies
Document
Date 06 Dec 2024
Title Director's Irrevocable Undertaking - Fabiana Lacerca-Allen
Document
Date 06 Dec 2024
Title Director's Irrevocable Undertaking - Dr Christian Schweiger
Document
Date 06 Dec 2024
Title Director's Irrevocable Undertaking - Anders Lundstrom
Document
Date 06 Dec 2024
Title AOP Relationship Agreement
Document
Date 06 Dec 2024
Title AOP Subscription Agreement
Document
Date 06 Dec 2024
Title AOP Accounts for the year ended 2023
Document
Date 06 Dec 2024
Title Articles of Association of AOP Health International Management AG
Document
Date 06 Dec 2024
Title AOP Accounts for the year ended 2022
Document
Date 04 Nov 2024
Title Q3 2024 Corporate Presentation
Presentation
Date 04 Nov 2024
Title Q3 2024 Trading Update IMC Presentation
Link
Date 09 Sep 2024
Title H1 2024 Interim Financials
Document
Date 05 Aug 2024
Title Corporate Presentation
Document
Date 20 Jun 2024
Title Results of 2024 Annual General Meeting
Document
Date 10 May 2024
Title Audited results for the year ended 31 December 2023
Document
Date 10 May 2024
Title Letter to Shareholders 2024
Document
Date 10 May 2024
Title Notice of Annual General Meeting 2024
Document
Date 10 May 2024
Title 2023 Annual Report and Accounts
Document
Date 30 Apr 2024
Title Business Update for Q1 2024 and Confirmation of Key Financials for FY 2023
Document
Presentation
Link
Date 28 Sep 2023
Title STX Interim Results 2023
Document
Date 28 Sep 2023
Title Interim results update and business update
Document
Date 29 Jun 2023
Title Results of 2023 Annual General Meeting
Document
Date 31 May 2023
Title Peel Hunt Consent Letter (2.7 Announcement)
Link
Date 31 May 2023
Title Peel Hunt Consent Letter (Offer Document)
Link
Date 31 May 2023
Title Numis Consent Letter (Offer Document)
Link
Date 31 May 2023
Title Numis Consent Letter (2.7 Announcement)
Link
Date 25 May 2023
Title Mandatory Cash Offer Document
Link
Date 25 May 2023
Title Letter from Peel Hunt
Link
Date 19 May 2023
Title Notice of Annual General Meeting 2023
Document
Date 19 May 2023
Title 2022 Annual Report and Accounts
Document
Date 19 May 2023
Title Letter to Shareholders
Document
Date 18 May 2023
Title Form 8 - PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Link
Date 09 May 2023
Title Rule 2.9 Announcement and Total Voting Rights Update
Link
Date 05 May 2023
Title Director's Irrevocable Undertaking- G Madison
Link
Date 05 May 2023
Title Director's Irrevocable Undertaking - HP Hasler
Link
Date 05 May 2023
Title Director's Irrevocable Undertaking- P Llewellyn-Davies
Link
Date 05 May 2023
Title Director's Irrevocable Undertaking- A Lundstrom
Link
Date 05 May 2023
Title Director's Irrevocable Undertaking - F Lacerca-Allen
Link
Date 04 May 2023
Title Letter of Intent – Jupiter Asset Management
Link
Date 04 May 2023
Title AOP Loan Conversion and Mandatory Cash Offer
Link
Date 04 May 2023
Title Rule 2.11 Letter to Shareholders and Optionholders
Link
Date 04 May 2023
Title Rule 2.11 Letter to Employees
Link
Date 27 Apr 2023
Title 2022 Final Results and Q1 2023 Update
Document
Date 27 Apr 2023
Title 2022 Final Results and Q1 2023 Update - Investor Presentation
Link
Date 27 Apr 2023
Title Business Update and Unaudited Results
Document
Date 05 Jan 2023
Title Results of 2023 General Meeting
Document
Date 16 Dec 2022
Title Extended Shareholder Loan Facility Placing, Subscription and Open Offer
Document
Date 14 Dec 2022
Title Investor Presentation
Presentation
Date 08 Sep 2022
Title Business Update and Interim Report for the six months ended 30 June 2022
Document
Date 27 Jul 2022
Title Results of 2022 Annual General Meeting
Document
Date 27 Jul 2022
Title Results of 2022 General Meeting
Document
Date 08 Jul 2022
Title Notice of General Meeting - Letter to Shareholders
Document
Date 08 Jul 2022
Title Notice of General Meeting
Document
Date 30 Jun 2022
Title Final Results for the year ended 31 December 2021
Presentation
Link
Date 30 Jun 2022
Title Annual Report 2021
Document
Date 30 Jun 2022
Title Notice of Annual General Meeting (“AGM”) 2022
Document
Date 30 Jun 2022
Title Notice of Annual General Meeting (“AGM”) 2022 - Letter to shareholders
Document
Date 03 Mar 2022
Title Investor Presentation
Presentation
Link
Date 10 Feb 2022
Title KOL Investor Event on Iron Deficiency
Link
Date 10 Jan 2022
Title H.C. Wainwright BIOCONNECT Virtual Conference
Presentation
Date 23 Sep 2021
Title Hardman & Co Life Sciences Investor Forum | September 2021
Presentation
Link
Date 17 Aug 2021
Title Interim Report for the six months ended 30 June 2021
Document
Presentation
Date 24 Jun 2021
Title Virtual Life Sciences Investor Forum
Link
Date 17 Jun 2021
Title AGM 2021 Results
Document
Date 13 May 2021
Title Notice of Annual General Meeting (“AGM”) 2021 - Letter to Shareholders
Document
Date 13 May 2021
Title Annual Report and Accounts for the year ended 31 December 2020
Document
Date 29 Apr 2021
Title Preliminary results for the Year Ended 31 December 2020
Document
Date 29 Apr 2021
Title Results for the Year Ended 31 December 2020 - Investor Presentation
Presentation
Date 08 Apr 2021
Title Proactive Investor 1-2-1 Forum
Presentation
Date 18 Mar 2021
Title Result of General Meeting & Open Offer
Document
Date 09 Mar 2021
Title IMC Presentation
Presentation
Date 01 Mar 2021
Title Shareholder Placing/Subscription Circular - Notice of GM
Document
Date 20 Jan 2021
Title Shares Magazine/AJ Bell Webinar
Presentation
Date 20 Jun 2006
Title Notice of Annual General Meeting (“AGM”) 2021
Document
Date 18 Jun 2021
Title Results of 2020 AGM
Document
Date 16 Dec 2020
Title Investor Meet Presentation
Presentation
Date 16 Sep 2020
Title Interim Results 2020
Document
Presentation
Date 24 Jun 2020
Title Quoted Companies Alliance Corporate Governance Code - Statement of compliance
Document
Date 22 May 2020
Title Notice of Annual General Meeting 2020
Document
Date 22 May 2020
Title Annual Report and Acounts 2019
Document
Date 22 May 2020
Title Notice of Annual General Meeting 2020 (Letter to Shareholders)
Document
Date 21 May 2020
Title Preliminary Results for the Year Ended 31 December 2019
Document
Date 07 Aug 2019
Title Interim Report for the six months ended 30 June 2019
Document
Date 13 Jun 2019
Title AGM 2019 Results
Document
Date 13 Jun 2019
Title Articles of Association
Document
Date 30 Apr 2019
Title Notice of Annual General Meeting 2019
Document
Date 30 Apr 2019
Title Notice of Annual General Meeting 2019 (Letter to Shareholders)
Document
Date 30 Apr 2019
Title Annual Report 2018
Document
Date 03 Apr 2019
Title Preliminary Results for the Year Ended 31 December 2018
Document
Date 28 Sep 2018
Title UK Corporate Governance Code disclosures
Document
Date 05 Jun 2018
Title Shield Therapeutics plc - AGM 2018 Shareholder Letter
Document
Date 05 Jun 2018
Title Shield Therapeutics plc - Notice of AGM 2018
Document
Date 05 Jun 2018
Title Shield Therapeutics Interim Results 2018
Document
Date 05 Jun 2018
Title Shield Therapeutics plc - Annual Report and Accounts for year ended 2017
Document
Date 11 Apr 2018
Title Shield Therapeutics Preliminary Results 2017
Document
Date 30 Jun 2017
Title Shield Therapeutics Interim Results 2017
Document
Date 28 Apr 2017
Title Annual Report 2016
Document
Date 28 Apr 2017
Title Notice of Annual General Meeting 2017
Document
Date 04 Apr 2017
Title 2016 Preliminary Results
Document
Date 20 Sep 2016
Title 2016 Interims Press Release
Document
Date 20 Sep 2016
Title 2016 Interim Report
Document
Date 15 Jul 2016
Title Notice of Annual General Meeting 2016
Document
Date 30 Jun 2016
Title Annual Report 2015
Document
Date 14 Jun 2016
Title Maiden Prelims Press Release
Document
Date 12 Jun 2016
Title Memorandum of Association
Document
Date 12 Jun 2016
Title Warrant Instrument
Document
Date 12 Jun 2016
Title Shield Therapeutics Announces Successful Placing to Raise £32.5 Million and Proposed Admission to AIM
Document
Date 12 Jun 2016
Title Admission Document
Document
About Us
Learn more
Corporate Governance
Learn more
Regulatory Announcements
Learn more